Active	Status	Sponsor type	Region	Phase	Filter
5 Active 0 Inactive 5 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   - « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   Show only changed items Enrollment:

Advanced Filters

5 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Armstrong, Ashley
PREVENTABLE, NCT04262206: Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults	Recruiting	4	20000	US	Atorvastatin 40 Mg Oral Tablet, Lipitor, Placebo oral tablet	Duke University, National Institute on Aging (NIA), National Heart, Lung, and Blood Institute (NHLBI), Wake Forest University Health Sciences	Cognitive Impairment, Mild, Dementia, Cardiovascular Diseases	12/26	12/26
Chamberlain, Alanna
PREVENTABLE, NCT04262206: Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults	Recruiting	4	20000	US	Atorvastatin 40 Mg Oral Tablet, Lipitor, Placebo oral tablet	Duke University, National Institute on Aging (NIA), National Heart, Lung, and Blood Institute (NHLBI), Wake Forest University Health Sciences	Cognitive Impairment, Mild, Dementia, Cardiovascular Diseases	12/26	12/26
Childress, Richard
PREVENTABLE, NCT04262206: Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults	Recruiting	4	20000	US	Atorvastatin 40 Mg Oral Tablet, Lipitor, Placebo oral tablet	Duke University, National Institute on Aging (NIA), National Heart, Lung, and Blood Institute (NHLBI), Wake Forest University Health Sciences	Cognitive Impairment, Mild, Dementia, Cardiovascular Diseases	12/26	12/26
VA-IMPACT, NCT02915198 / 2018-000635-27: Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes	Recruiting	4	7410	US	Metformin XR, Placebo	VA Office of Research and Development	Prediabetic State, Atherosclerosis, Metformin	03/29	03/29
Beaverson, Brandon
PREVENTABLE, NCT04262206: Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults	Recruiting	4	20000	US	Atorvastatin 40 Mg Oral Tablet, Lipitor, Placebo oral tablet	Duke University, National Institute on Aging (NIA), National Heart, Lung, and Blood Institute (NHLBI), Wake Forest University Health Sciences	Cognitive Impairment, Mild, Dementia, Cardiovascular Diseases	12/26	12/26

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Armstrong, Ashley
PREVENTABLE, NCT04262206: Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults	Recruiting	4	20000	US	Atorvastatin 40 Mg Oral Tablet, Lipitor, Placebo oral tablet	Duke University, National Institute on Aging (NIA), National Heart, Lung, and Blood Institute (NHLBI), Wake Forest University Health Sciences	Cognitive Impairment, Mild, Dementia, Cardiovascular Diseases	12/26	12/26
Chamberlain, Alanna
PREVENTABLE, NCT04262206: Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults	Recruiting	4	20000	US	Atorvastatin 40 Mg Oral Tablet, Lipitor, Placebo oral tablet	Duke University, National Institute on Aging (NIA), National Heart, Lung, and Blood Institute (NHLBI), Wake Forest University Health Sciences	Cognitive Impairment, Mild, Dementia, Cardiovascular Diseases	12/26	12/26
Childress, Richard
PREVENTABLE, NCT04262206: Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults	Recruiting	4	20000	US	Atorvastatin 40 Mg Oral Tablet, Lipitor, Placebo oral tablet	Duke University, National Institute on Aging (NIA), National Heart, Lung, and Blood Institute (NHLBI), Wake Forest University Health Sciences	Cognitive Impairment, Mild, Dementia, Cardiovascular Diseases	12/26	12/26
VA-IMPACT, NCT02915198 / 2018-000635-27: Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes	Recruiting	4	7410	US	Metformin XR, Placebo	VA Office of Research and Development	Prediabetic State, Atherosclerosis, Metformin	03/29	03/29
Beaverson, Brandon
PREVENTABLE, NCT04262206: Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults	Recruiting	4	20000	US	Atorvastatin 40 Mg Oral Tablet, Lipitor, Placebo oral tablet	Duke University, National Institute on Aging (NIA), National Heart, Lung, and Blood Institute (NHLBI), Wake Forest University Health Sciences	Cognitive Impairment, Mild, Dementia, Cardiovascular Diseases	12/26	12/26